BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Medical Device Innovation Consortium Announces CEO William V. Murray is Stepping Down to Return to Private Sector; Board Begins Search for New Leader

  The Medical Device Innovation Consortium (MDIC) CEO William V. (Bill) Murray today announced he will step down as President & CEO effective February 2, 2018 to return to the private sector.

  November 9, 2017

   · 

  2 min read
• Business

  FibroGen Reports Third Quarter 2017 Financial Results

  FibroGen will host a conference call and webcast today, November 8, 2017, at 5:00 p.m. ET to discuss financial results and provide a business update.

  November 9, 2017

   · 

  11 min read
• Business

  Collegium Reports Third Quarter Financial Results and Provides Corporate Update - Nov. 9, 2017

  Net product revenues for Xtampza ER for the 2017 Quarter were $12.0 million ($7.6 million without the one-time $4.4 million increase) compared to $408,000 for the quarter ended September 30, 2016 (the “2016 Quarter”).

  November 9, 2017

   · 

  14 min read
• Business

  Otonomy Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Conference call and webcast today at 4:30 p.m. EST

  November 9, 2017

   · 

  12 min read
• Business

  Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results

  Total revenue was $2.6 million for the three months ended September 30, 2017, compared to $12.5 million for the same period in 2016.

  November 9, 2017

   · 

  15 min read
• Deals

  Fuse Medical Signs Non-Binding Letter of Intent to Purchase all of the Outstanding Membership Units of CPM Medical Consultants, LLC

  Although no binding obligation will be created until the execution of a definitive purchase agreement, the Company and the members of CPM are currently negotiating the definitive purchase agreement with a targeted fourth quarter close date.

  November 9, 2017

   · 

  3 min read
• Business

  Alcami Announces Manufacturing Agreement for Solasia’s Active Pharmaceutical Ingredient Darinaparsin

  The company has finalized manufacturing and quality agreements with Solasia Pharma, K.K.

  November 9, 2017

   · 

  2 min read
• Genetown

  Brooks Life Sciences Bolsters Bioprocessing Capabilities Through Expansion of Sample Preparation Services in Germany

  The company has expanded its sample preparation and bioprocessing laboratory service.

  November 9, 2017

   · 

  3 min read
• Business

  Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results

  Trovagene made significant progress in the third quarter to advance the clinical research of PCM-075 for solid and hematologic tumor cancers.

  November 9, 2017

   · 

  19 min read
• Business

  Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results

  Top-line results from MGL-3196 Phase 2 clinical trials in NASH and HeFH expected in late 2017 and early 2018, respectively.

  November 9, 2017

   · 

  9 min read